Kodi-M Co Ltd Total Liabilities

Latest as of June 2026: ₩69.73 Billion KRW ≈ $47.25 Million USD

Kodi-M Co Ltd total liabilities. Based on the latest financial reports, Kodi-M Co Ltd (224060) has total liabilities worth ₩69.73 Billion KRW (≈ $47.25 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 224060 financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Kodi-M Co Ltd (2015–2025)

Total liabilities of Kodi-M Co Ltd from 2015 to 2025. This chart illustrates how Kodi-M Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 224060 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Kodi-M Co Ltd Competitors by Total Liabilities

The table below lists competitors of Kodi-M Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Seacera Group Bhd
KLSE:7073
Malaysia RM130.81 Million
Micronet Ltd
TA:MCRNT
Israel ILA612.00K
In8bio Inc
NASDAQ:INAB
USA $3.38 Million
Praxis Home Retail Limited
NSE:PRAXIS
India Rs2.60 Billion
Eastern International Ltd.
NASDAQ:ELOG
USA $17.09 Million
ReShape Lifesciences Inc
NASDAQ:RSLS
USA $3.20 Million
TEN Holdings, Inc. Common Stock
NASDAQ:XHLD
USA $3.07 Million
Pergamon Status Dis Ticaret AS
IS:PSDTC
Turkey TL4.93 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Kodi-M Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Kodi-M Co Ltd total assets.

Liquidity & Leverage Metrics

Kodi-M Co Ltd Total Liabilities Ratios Explained

Kodi-M Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.26 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.59 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.94 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kodi-M Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kodi-M Co Ltd (2015–2025)

The table below shows the annual total liabilities of Kodi-M Co Ltd from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 ₩61.56 Billion
≈ $41.72 Million
+26.00%
2024-12-31 ₩48.86 Billion
≈ $33.11 Million
-27.32%
2023-12-31 ₩67.22 Billion
≈ $45.56 Million
+44.04%
2022-12-31 ₩46.67 Billion
≈ $31.63 Million
-30.14%
2021-12-31 ₩66.80 Billion
≈ $45.27 Million
+48.12%
2020-12-31 ₩45.10 Billion
≈ $30.56 Million
-12.47%
2019-12-31 ₩51.52 Billion
≈ $34.92 Million
+36.97%
2018-12-31 ₩37.62 Billion
≈ $25.49 Million
+561.81%
2017-12-31 ₩5.68 Billion
≈ $3.85 Million
-89.14%
2016-12-31 ₩52.34 Billion
≈ $35.47 Million
+570.96%
2015-12-31 ₩7.80 Billion
≈ $5.29 Million
--

About Kodi-M Co Ltd

KQ:224060 Korea Semiconductor Equipment & Materials
Market Cap
$9.36 Million
₩13.81 Billion KRW
Market Cap Rank
#27108 Global
#2025 in Korea
Share Price
₩2690.00
Change (1 day)
-5.28%
52-Week Range
₩2430.00 - ₩9890.00
All Time High
₩360000.00
About

THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agents for various diseases, such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy to treat cancer and inflammatory diseases. THE CODI Co.,LTD. was formerly known as CODI-M Co., LTD. and chang… Read more